<!DOCTYPE html>
<html>

<head>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
	 <meta name="description" content="Get a comprehensive updated vision on senotherapy and senolytics and efficiently target senescent cells, main responsible in age-related diseases. * "/>


    <title>Senolytix - Discover senolytics, futur of anti-aging research</title>

    <!-- Bootstrap CSS CDN -->
    <link rel="stylesheet" href="https://stackpath.bootstrapcdn.com/bootstrap/4.1.0/css/bootstrap.min.css" integrity="sha384-9gVQ4dYFwwWSjIDZnLEWnxCjeSWFphJiwGPXr1jddIhOegiu1FwO5qRGvFXOdJZ4" crossorigin="anonymous">
    <!-- Our Custom CSS -->
    <link rel="stylesheet" href="style5.css">

    <!-- Font Awesome JS -->
    <script defer src="https://use.fontawesome.com/releases/v5.0.13/js/solid.js" integrity="sha384-tzzSw1/Vo+0N5UhStP3bvwWPq+uvzCMfrN1fEFe+xBmv1C/AtVX5K0uZtmcHitFZ" crossorigin="anonymous"></script>
    <script defer src="https://use.fontawesome.com/releases/v5.0.13/js/fontawesome.js" integrity="sha384-6OIrr52G08NpOFSZdxxz1xdNSndlD4vdcf/q2myIUVO0VsqaGHJsB0RaBE01VTOY" crossorigin="anonymous"></script>
<style>

body {
    font-family: 'Poppins', sans-serif;
    background: #fafafa;
}


p {
    font-family: 'Poppins', sans-serif;
    font-size: 1.1em;
    font-weight: 300;
    line-height: 1.7em;
    color: #999;
}

a, a:hover, a:focus {
    padding-left:1em;
    color: inherit;
    text-decoration: none;
    transition: all 0.3s;
}

.navbar {
    padding: 15px 10px;
    background: #fff;
    border: none;
    border-radius: 0;
    margin-bottom: 40px;
    box-shadow: 1px 1px 3px rgba(0, 0, 0, 0.1);
}

.navbar-btn {
    box-shadow: none;
    outline: none !important;
    border: none;
}

.line {
    width: 100%;
    height: 1px;
    border-bottom: 1px dashed #ddd;
    margin: 40px 0;
}

/* ---------------------------------------------------
    SIDEBAR STYLE
----------------------------------------------------- */

.wrapper {
    display: flex;
    width: 100%;
    align-items: stretch;
    perspective: 1500px;
	 
}


#sidebar {
 position: -webkit-sticky;
  position: sticky;
    min-width: 250px;
    max-width: 250px;
    background: #7386D5;
    color: #fff;
    transition: all 0.6s cubic-bezier(0.945, 0.020, 0.270, 0.665);
    transform-origin: bottom left;
	
}

#sidebar.active {

    margin-left: -250px;
    transform: rotateY(100deg);
}

#sidebar .sidebar-header {
    padding: 20px;
    background: #6d7fcc;
}

#sidebar ul.components {
    padding: 20px 0;
    border-bottom: 1px solid #47748b;
}

#sidebar ul p {
    color: #fff;
    padding: 10px;
}

#sidebar ul li a {
    padding: 10px;
    font-size: 1.1em;
    display: block;
}
#sidebar ul li a:hover {
    color: #7386D5;
    background: #fff;
}

#sidebar ul li.active > a, a[aria-expanded="true"] {
    color: #fff;
    background: #6d7fcc;
}


a[data-toggle="collapse"] {
    position: relative;
}

.dropdown-toggle::after {
    display: block;
    position: absolute;
    top: 50%;
    right: 20px;
    transform: translateY(-50%);
}

ul ul a {
    font-size: 0.9em !important;
    padding-left: 30px !important;
    background: #6d7fcc;
}

ul.CTAs {
    padding: 20px;
}

ul.CTAs a {
    text-align: center;
    font-size: 0.9em !important;
    display: block;
    border-radius: 5px;
    margin-bottom: 5px;
}

a.download {
    background: #fff;
    color: #7386D5;
}

a.article, a.article:hover {
    background: #6d7fcc !important;
    color: #fff !important;
}



/* ---------------------------------------------------
    CONTENT STYLE
----------------------------------------------------- */
#content {
    width: 100%;
    padding: 20px;
    min-height: 100vh;
    transition: all 0.3s;
}

#sidebarCollapse {
    width: 40px;
    height: 40px;
    background: #f5f5f5;
    cursor: pointer;
}

#sidebarCollapse span {
    width: 80%;
    height: 2px;
    margin: 0 auto;
    display: block;
    background: #555;
    transition: all 0.8s cubic-bezier(0.810, -0.330, 0.345, 1.375);
    transition-delay: 0.2s;
}

#sidebarCollapse span:first-of-type {
    transform: rotate(45deg) translate(2px, 2px);
}
#sidebarCollapse span:nth-of-type(2) {
    opacity: 0;
}
#sidebarCollapse span:last-of-type {
    transform: rotate(-45deg) translate(1px, -1px);
}


#sidebarCollapse.active span {
    transform: none;
    opacity: 1;
    margin: 5px auto;
}


/* ---------------------------------------------------
    MEDIAQUERIES
----------------------------------------------------- */
@media (max-width: 768px) {
    #sidebar {
        margin-left: -250px;
        transform: rotateY(90deg);
    }
    #sidebar.active {
        margin-left: 0;
        transform: none;
    }
    #sidebarCollapse span:first-of-type,
    #sidebarCollapse span:nth-of-type(2),
    #sidebarCollapse span:last-of-type {
        transform: none;
        opacity: 1;
        margin: 5px auto;
    }
    #sidebarCollapse.active span {
        margin: 0 auto;
    }
    #sidebarCollapse.active span:first-of-type {
        transform: rotate(45deg) translate(2px, 2px);
    }
    #sidebarCollapse.active span:nth-of-type(2) {
        opacity: 0;
    }
    #sidebarCollapse.active span:last-of-type {
        transform: rotate(-45deg) translate(1px, -1px);
    }

}
.center {
  display: block;
  margin-left: auto;
  margin-right: auto;
}

img
{
max-width: 100%;
max-height: 100%;
}
</style>
	
</head>

<body>

    <div class="wrapper">
        <!-- Sidebar Holder -->
        <nav id="sidebar" >
            <div class="sidebar-header">
                <h3>Quick search</h3>
            </div>

            <ul class="list-unstyled components">
				<li>
                <a  href="http://www.senolytix.org/">Home</a>
				</li>
			<li>
                <a  href="#">Senescent cell</a>
				</li>
				<li>
<a  href="#"> Senescence biomarkers</a>
</li>
  <!-- Links -->
  <li>
    <li class="nav-item dropdown">
	<li>
      <a class="nav-link dropdown-toggle" href="#" id="navbardrop" data-toggle="dropdown">
       Targeted senotherapy 
      </a>
	 
      <div class="dropdown-menu">
        <a class="dropdown-item" href="#">Senolytics</a>
        <a class="dropdown-item" href="#">Nanosystems</a>

      </div>
    </li>
  </li>
  <li>
   <a href="#">AI and senotherapy</a>
   </li>
   <li>
   <a href="#">Senotherapy and senolytics market</a>
   </li>
            </ul>
<a>next update: 17/04/2020</a>
<a>contact: jrepusseau@gmail.com</a>
        </nav>

        <!-- Page Content Holder -->
        <div id="content">

            <nav class="navbar navbar-expand-lg navbar-light bg-light sticky-top">
                <div class="container-fluid" >

                    <button type="button" id="sidebarCollapse" class="navbar-btn">
                        <span></span>
                        <span></span>
                        <span></span>
                    </button>
					
					<h1 class='nav navbar-nav mx-auto'> Senolytix </h1>
                    <button class="btn btn-dark d-inline-block d-lg-none ml-auto" type="button" >
                        <i class="fa fa-envelope"></i>
                    </button>

                   
                </div>
            </nav>
			
      
            <div>
             <br>
			  <h2>Senescent cells</h2>
			  <p>
			  Senescence is a dynamic multistep process that conducts cells to cycle arrest. The senescent cells undergo change in viability, enlarged size and irregular shape, growth arrest, loss of lamin B1, resistance to apoptosis, over expression of p16, p21 gene activation,  a mitochondrial overactivity resulting by a high senescence-associated β-galactosidase (SA-β-gal) activity and Reactive Oxygen Species (ROS) concentration, lipofucin accumulation, and secretion senescence-associated secretory phenotype (SASP). 
</p><br><p>
During their life, all cells undergo intrinsic and extrinsic insults which in return active a signal, the DNA damage response (DDR) leading to repair damages made to the protein 53 (p53), responsible for cell cycle, autophagy and apoptosis. However, a persistent DDR from intrinsic (oxidative damage, telomere attrition, hyper proliferation) or external insults (UV, y-irradiation, cytotoxic drugs, nutrition depletion) can lead to cell senescence. 
</p><br><p>
Hayflick and Moorhead first described that through multiple division, telomere erosion activates a persistent DDR that further leads to cell senescence. This type of senescence,  also called replicative senescence (RS) is the most observed type of senescence. 

Damaged induced senescence (DIS) requires the use of ROS inhibitors such as anticancer drugs or radiation.
Oncogene induced senescence (OIS) can be induced by activation of sarcoma viral oncogene homolog (RAS) or v-raf murine sarcoma viral oncogene homolog B (BRAF). RAS activation increases proliferation rate that causes direct persistent DNA damage then senescence. Activation of BRAF involves p16 induction, then regulation of the inflammatory interleukins IL-6, IL-8 and activation of pyruvate dehydrogenase (PDH). PDH activation then leads to increased mitochondrial metabolism, which in turn increases ROS production then DDR. 
</p><br><p>
DDR stimuli will activate  the p53/p21 axis inducing senescence or apoptosis in order to  prevent cancer cell formation. In the nucleus, p53 induces the transcription of the cyclin-dependent kinase inhibitor p21, which in turn blocks CDK2 activity , resulting in hypophosphorylated retinoblastoma proteins (Rb). p53/p21 signalling will also increase ROS production inducing DNA damages and causing the cell cycle arrest. The INK4/ARF locus triggers cell cycle arrest/senescence and apoptosis by encoding three tumor suppressors, ARF and p16, encoded by CDKN2A, and  p15 , encoded by CDKN2B.  
DDR  activates serine/threonine kinase ATM which are proteins responsible to check DNA damage, leading to cell cycle arrest, DNA repair or apoptosis. In case ATM checkpoints are disabled and the oncogenic stimuli increase ARF is activated to preserve p53 degradation from DDR by either inducing senescence or apoptotic. p15 and p16 selectively inhibit CDK4 and CDK6 that keeps the Rb hypophosphorylated and enforcing the cell cycle arrest.  While p53/p21 induced the senescent response, p16 maintains the senescence process in the cell.  
</p><br><p>
By p38 mediation, p16 locks the cell in senescence via a constant oxidative stress and generation of DDR. p16 mutations leading to senescence evasion may be the most frequent cause of malignant cell development. 
DDR triggers the biosynthesis of SASP regulated by mammalian targets of rapamycin (mTOR).  The first complex of mTOR (mTORC1)  interplay with endoplasmic reticulum (ER) to secure protein production and maintain senescent cell anti-apoptotic pathways (SCAP). mTORC1 increases the biosynthesis and leads to accumulation of misfolded/unfolded proteins and so the demand for ER mitochondries. ER stress will directly inhibit AKT, a survival kinase responsible for autophagy signaling. Autophagy increases the dysfunctional mitochondria leading to oxidative phosphorylation and endogenous ROS formation. Conversely, prolonged ER stress induces the activation of the P13K pathway leading to an activation AKT, inhibition in autophagy and mTORC1 activity.
</p><br><p>
DDR signaling activate several agent responsible for SASP production such as  nuclear factor kB (NF-kβ), mitochondrial dysfunction-associated senescence (MiDAS), GATA4, and CCAAT/enhancer-binding protein-β (C/EBPβ). NF-kβ and C/EBPβ mainly regulate SASP by controlling inflammatory interleukins (IL-4) and (IL-8). 
SASP factors can be globally divided into  soluble factors (interleukins, chemokines, growth factors and secreted proteases) and secreted insoluble proteins / ECM components.
 Pro inflammatory and immunomodulatory cytokines and chemokines include interleukins (IL-6, IL-7, IL-8), monocyte chemoattractant protein (MCP-2) and macrophage inflammatory protein (MIP)-3a. Secreted growth factors include growth Regulated Oncogene alpha (GROa), hepatocyte growth factor (HGF), insulin-like growth factor binding protein (IGFBP) and . Among secreted proteases, matrix metalloproteinases (MMPs) family and serine  proteases (ICAMs, uPAR, TNF receptors). ECM components include collagens and miminin. 
</p><br><p>
Senescence mechanism limits the replication of old and damaged cells in order to prevent malignancy by blocking replication. Senescent cells also contribute to wound healing and resolution. The SASP plays a major role in cancer proliferation. Growth factors notably increase tumor growth and vascularization where factors such as MMP-2 can also lead to inhibition of anti-tumour T-cell responses thus premalignant and malignant cells immune evasion. Also SASP induces senescence to neighbours cells in an autocrine and paracrine manner. Accumulation  of senescent cell drive aging and age related disease backed from the systematic observation of SC in age related disease and the selective killing of SC (senotherapy) decrease aging and age-related disease. 


			  
			  </p>

   </div>
     <!-- jQuery CDN - Slim version (=without AJAX) -->
    <script src="https://code.jquery.com/jquery-3.3.1.slim.min.js" integrity="sha384-q8i/X+965DzO0rT7abK41JStQIAqVgRVzpbzo5smXKp4YfRvH+8abtTE1Pi6jizo" crossorigin="anonymous"></script>
    <!-- Popper.JS -->
    <script src="https://cdnjs.cloudflare.com/ajax/libs/popper.js/1.14.0/umd/popper.min.js" integrity="sha384-cs/chFZiN24E4KMATLdqdvsezGxaGsi4hLGOzlXwp5UZB1LY//20VyM2taTB4QvJ" crossorigin="anonymous"></script>
    <!-- Bootstrap JS -->
    <script src="https://stackpath.bootstrapcdn.com/bootstrap/4.1.0/js/bootstrap.min.js" integrity="sha384-uefMccjFJAIv6A+rW+L4AHf99KvxDjWSu1z9VI8SKNVmz4sk7buKt/6v9KI65qnm" crossorigin="anonymous"></script>

       <script type="text/javascript">
        $(document).ready(function () {
            $('#sidebarCollapse').on('click', function () {
                $('#sidebar').toggleClass('active');
                $(this).toggleClass('active');
            });
        });
    </script>
</body>

</html>